The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,002,407 in first-year total cost, median $177,778.
Most frequent study sections
- Special Emphasis Panel[ZCA1 SRB-1 (M1)]11
Most frequent institutions
- DANA-FARBER CANCER INST1
- FRED HUTCHINSON CANCER CENTER1
- HARVARD MEDICAL SCHOOL1
- MAINEHEALTH1
- MASSACHUSETTS GENERAL HOSPITAL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | Molecular origins and evolution to treatment resistance in genitourinary cancers1R50CA265182-01A1 | PARK, JIHYE | DANA-FARBER CANCER INST, MA | $330,413 | ZCA1 |
| 2022 | A proteomics research specialist in developing targeted mass spectrometry methods for quantifying proteins important in cancer2R50CA211499-06A1 | WHITEAKER, JEFF | FRED HUTCHINSON CANCER CENTER, WA | $310,761 | ZCA1 |
| 2022 | Comprehensive Informatic Analyses of AML Genomes and Epigenomes2R50CA211782-06 | MILLER, CHRISTOPHER A | WASHINGTON UNIVERSITY, MO | $195,422 | ZCA1 |
| 2022 | Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images1R50CA274277-01 | LIN, JIA-REN | HARVARD MEDICAL SCHOOL, MA | $180,221 | ZCA1 |
| 2022 | The Immortality and Evolution of Adult Brain Tumors1R50CA274229-01 | HONG, CHIBO | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $179,819 | ZCA1 |
| 2022 | Dissecting the in vivo stromal metabolic and inflammatory crosstalk in colorectal cancer1R50CA265332-01A1 | DURAN MOLINA, MARIA ANGELES | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $177,778 | ZCA1 |
| 2022 | BRCA-dependent Mechanisms of Genome Maintenance and Repair1R50CA265315-01A1 | KWON, YOUNGHO | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | $164,435 | ZCA1 |
| 2022 | Computational Approaches for Studying Transcription Elongation Control in Cancer1R50CA265372-01A1 | IWANASZKO, MARTA | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $144,392 | ZCA1 |
| 2022 | Developing therapeutic TCR mimic monoclonal antibodies for cancer1R50CA265328-01A1 | DAO, TAO | SLOAN-KETTERING INST CAN RESEARCH, NY | $135,201 | ZCA1 |
| 2022 | Research Specialist Support for Defining the Roles of Bone Marrow Adipocytes and FABP4/5 Signaling in Multiple Myeloma1R50CA265331-01A1 | CAMPBELL, HEATHER F | MAINEHEALTH, ME | $99,576 | ZCA1 |
| 2022 | Understanding and targeting RNA/transcription-dependent DNA repair in cancer cells1R50CA274158-01 | OUYANG, JIAN | MASSACHUSETTS GENERAL HOSPITAL, MA | $84,389 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.